工具
选股器
从StockVane跟踪的3753只美股大盘股中筛选,并可按任意列排序。结果中的量化评级与个股页面上显示的一致。
176 个匹配结果
| 公司 | 60日 | 最新价 | 涨跌幅 | 市值 | 市盈率 | 股息率 | 近一年 | 量化评级 ↑ |
|---|---|---|---|---|---|---|---|---|
| Aktis OncologyAKTS | 15.06 | -5.93% | $837.63M | -- | -- | -- | C 0 | |
| ApnimedAPMD | 17.76 | -2.66% | $739.36M | 4.56 | -- | -- | C 0 | |
| Attovia TherapeuticsATTO | 13.73 | -7.10% | $626.79M | -- | -- | -- | C 0 | |
| Avalyn PharmaAVLN | 23.66 | -3.98% | $1.05B | -- | -- | -- | C 0 | |
| BlossomHill TherapeuticsBLSM | 13.94 | -6.94% | $443.08M | -- | -- | -- | C 0 | |
| ELECTRA THERAPEUTICS INCETRA | 8.75 | 0.00% | $534.63M | -- | -- | -- | C 0 | |
| Latigo BiotherapeuticsLTGO | 14.00 | -5.15% | $928.19M | -- | -- | -- | C 0 | |
| Obsidian TherapeuticsOBX | 11.77 | -3.52% | $727.07M | 18.11 | -- | -- | C 0 | |
| Odyssey TherapeuticsODTX | 17.17 | -2.28% | $825.16M | -- | -- | -- | C 0 | |
| SpyGlass PharmaSGP | 24.00 | -2.91% | $802.75M | -- | -- | -- | C 0 | |
| SL ScienceSLBT | 1.53 | -1.29% | $857.96M | -- | -- | -85.2% | E 0 | |
| Seaport TherapeuticsSPTX | 17.83 | +1.31% | $954.45M | -- | -- | -- | C 0 | |
| Theravance Biopharma(Delisted)TBPH | 17.03 | 0.00% | $884.18M | 16.38 | -- | -- | C 0 | |
| VeradermicsMANE | 108.82 | -5.43% | $4.55B | -- | -- | -- | C 0 | |
| Parabilis MedicinesPBLS | 22.75 | -9.65% | $2.81B | -- | -- | -- | C 0 | |
| AtaiBeckleyATAI | 0.00 | 0.00% | $0 | -- | -- | -- | C 0 | |
| Braveheart BioBRVE | 18.71 | -4.30% | $1.68B | -- | -- | -- | C 0 | |
| Generate BiomedicinesGENB | 12.09 | -7.43% | $1.55B | -- | -- | -- | C 0 | |
| Hemab Therapeutics HoldingsCOAG | 30.07 | -7.53% | $1.40B | -- | -- | -- | C 0 | |
| KardiganKARD | 13.03 | -6.12% | $1.22B | -- | -- | -- | C 0 | |
| Kailera TherapeuticsKLRA | 11.25 | -3.93% | $1.46B | -- | -- | -- | C 0 | |
| OculisOCS | 7.29 | -1.49% | $448.98M | -- | -- | -66.5% | E 2 | |
| uniQure NVQURE | 21.78 | -3.29% | $1.51B | -- | -- | -62.4% | E 2 | |
| Sana BiotechnologySANA | 2.27 | -8.28% | $679.55M | -- | -- | -54.9% | E 3 | |
| Wave Life SciencesWVE | 3.13 | -1.88% | $617.32M | -- | -- | -59.9% | E 3 | |
| Ascentage PharmaAAPG | 15.37 | +4.63% | $1.44B | -- | -- | -56.6% | E 3 | |
| Intellia TherapeuticsNTLA | 11.42 | +0.71% | $1.60B | -- | -- | -53.9% | E 4 | |
| Ultragenyx PharmaceuticalRARE | 14.54 | -4.15% | $1.43B | -- | -- | -55.4% | E 4 | |
| Alnylam PharmaceuticalsALNY | 231.83 | -0.94% | $31.02B | 40.39 | -- | -51.9% | E 5 | |
| NewAmsterdam PharmaNAMS | 19.83 | -3.83% | $2.37B | -- | -- | -45.5% | E 5 | |
| Recursion PharmaceuticalsRXRX | 3.47 | -16.71% | $2.07B | -- | -- | -40.9% | E 5 | |
| Phathom PharmaceuticalsPHAT | 6.92 | -7.73% | $559.83M | -- | -- | -46.6% | E 6 | |
| ValnevaVALN | 5.61 | -5.08% | $531.96M | -- | -- | -44.1% | E 6 | |
| DBV TechnologiesDBVT | 9.05 | -0.66% | $568.78M | -- | -- | -46.6% | E 7 | |
| InventivaIVA | 2.94 | -5.47% | $694.53M | -- | -- | -39.4% | E 7 | |
| RegenxbioRGNX | 6.93 | -3.28% | $457.14M | -- | -- | -41.0% | E 7 | |
| Legend BiotechLEGN | 18.48 | -6.67% | $3.59B | -- | -- | -42.2% | E 7 | |
| ArdelyxARDX | 3.09 | -5.50% | $797.80M | -- | -- | -38.6% | E 8 | |
| Janux TherapeuticsJANX | 16.51 | -4.68% | $1.01B | -- | -- | -38.3% | D 8 | |
| Vor BiopharmaVOR | 18.03 | -6.77% | $1.07B | 1.56 | -- | -37.8% | D 8 | |
| InsmedINSM | 96.27 | -2.96% | $21.02B | -- | -- | -41.9% | E 8 | |
| Ionis PharmaceuticalsIONS | 42.94 | -2.67% | $7.14B | -- | -- | -41.3% | E 8 | |
| Ocular TherapeutixOCUL | 6.87 | -6.91% | $1.51B | -- | -- | -42.0% | E 8 | |
| MannKindMNKD | 3.04 | -4.70% | $977.50M | -- | -- | -44.4% | E 8 | |
| ImmaticsIMTX | 6.73 | -5.74% | $1.01B | -- | -- | -31.8% | E 9 | |
| BiohavenBHVN | 10.78 | -5.69% | $1.63B | -- | -- | -32.4% | E 9 | |
| Ginkgo BioworksDNA | 10.27 | -12.67% | $691.58M | -- | -- | -22.5% | D 11 | |
| CorMedixCRMD | 7.26 | -2.68% | $565.88M | 3.33 | -- | -28.7% | E 12 | |
| CytomXCTMX | 2.28 | -5.39% | $496.81M | -- | -- | -28.8% | E 12 | |
| CRISPR TherapeuticsCRSP | 49.25 | -4.41% | $4.76B | -- | -- | -28.8% | E 12 | |
| Taysha Gene TherapiesTSHA | 3.62 | -2.95% | $1.18B | -- | -- | -23.3% | E 12 | |
| Viking TherapeuticsVKTX | 25.17 | -8.04% | $3.20B | -- | -- | -24.9% | E 14 | |
| Disc MedicineIRON | 56.84 | +0.34% | $2.18B | -- | -- | -36.8% | D 15 | |
| Structure TherapeuticsGPCR | 21.08 | -5.00% | $1.50B | -- | -- | -23.0% | E 15 | |
| MesoblastMESO | 13.28 | -4.80% | $1.73B | -- | -- | -22.2% | D 15 | |
| Monopar TherapeuticsMNPR | 69.27 | -3.52% | $464.95M | -- | -- | -13.6% | D 17 | |
| Sarepta TherapeuticsSRPT | 17.10 | -3.88% | $1.81B | -- | -- | -24.0% | D 17 | |
| NanobiotixNBTX | 21.30 | -4.18% | $1.08B | -- | -- | -16.8% | D 17 | |
| Rhythm PharmaceuticalsRYTM | 86.17 | -2.05% | $5.93B | -- | -- | -21.9% | D 19 | |
| Zai LabZLAB | 23.19 | -1.36% | $2.60B | -- | -- | -18.0% | D 19 |
仅供参考,不构成投资建议。筛选结果是研究的起点,而非买入清单。量化评级方法详见数据与方法说明。